glp 1 blog GLP-1 Compounding: When Innovation May Mean Liability GLP‑1 real‑world data for obesity:
Description
doi: 10.1089/rej.2013.1419 191 ChiT-CChenW-PChiT-LKuoT-FLeeS-SChengJ-Tet al
The FDA says compounded drugs are not FDA-approved , meaning FDA does not verify their safety, effectiveness, or quality before they are marketed
Therefore, GLP-1RAs need to pass through the blood-brain barrier to exert their pharmacological effects
The most common side effects are related to the digestive system and can include nausea, vomiting, diarrhoea and constipation
Wegovy slows gastric emptying as part of its mechanism of action, which contributes to increased satiety but can also delay the absorption of other orally administered substances
